Nakano T, Yasumatsu R, Hashimoto K, Kuga R, et al. Real-world Experience With Pembrolizumab for Advanced-stage Head and Neck Cancer Patients: A Retrospective, Multicenter Study. Anticancer Res 2022;42:3653-3664.
PMID: 35790253